文献速递骨质疏松与代谢性骨病

理解骨质疏松患者治疗偏好:患者特征对亚组与潜在类别的影响

Understanding patients' preferences for osteoporosis treatment: the impact of patients' characteristics on subgroups and latent classes.
PubMed 文献 · Osteoporos Int · 2019-10-12

该研究基于188例骨质疏松患者的离散选择实验数据,用混合logit模型和潜在类别模型分析患者对抗骨质疏松药物疗效、副作用及给药方式的偏好异质性。结果显示多数属性存在显著异质性,有既往骨折者最重视疗效,恐针或>65岁者偏好口服片剂,老年人不喜欢静脉给药;识别出三个潜在类别,其中两类(86%)偏好6个月皮下注射,第三类(14%)偏好口服片剂,且未发现偏好类别与社会人口学或临床特征有统计学显著关联。

要点

  • 有既往骨折的患者最重视疗效,恐针或年龄>65岁的患者偏好口服片剂,老年患者不喜欢静脉给药。
  • 识别出三个潜在类别:两类(86%)偏好6个月皮下注射,第三类(14%)偏好口服片剂。
  • 偏好类别与社会人口学或临床特征之间未发现统计学显著关联。

核心结论

  • 骨质疏松患者的治疗偏好呈现不同模式,但这些模式无法归因于特定的社会人口学或临床特征。
  • 因此应让患者参与临床决策以了解其偏好,从而改善照护与治疗质量及依从性。

研究设计与样本

  • 研究使用188例骨质疏松患者的离散选择实验数据,假设治疗选项由疗效、副作用和给药方式/频率三个属性构成。
  • 采用混合logit模型测量样本异质性,并进行亚组分析以识别患者特征的潜在影响。
  • 应用潜在类别模型(LCM),并用卡方检验探索患者特征与识别出的潜在类别之间的关联。

主要发现

  • 所有治疗选项对患者的骨质疏松治疗决策均重要,大多数属性观察到显著异质性。
  • 亚组分析显示有既往骨折的患者最重视疗效,恐针或年龄>65岁的患者偏好口服片剂,老年患者不喜欢静脉给药。
  • 识别出三个潜在类别,其中两类(86%)偏好6个月皮下注射,第三类(14%)偏好口服片剂。
  • 未发现偏好类别与社会人口学或临床特征之间存在统计学显著关联。

关键数值与推荐

  • 188例骨质疏松患者完成离散选择实验。
  • 两类潜在类别(86%)偏好6个月皮下注射,第三类(14%)偏好口服片剂。
  • 有既往骨折的患者最重视疗效;恐针或年龄>65岁的患者偏好口服片剂;老年患者不喜欢静脉给药。

临床怎么用

  • 患者偏好存在异质性且无法用社会人口学或临床特征预测,应让患者参与临床决策以了解其偏好。
  • 无论患者特征如何,都应让患者在治疗选择中发挥积极作用,以改善照护与治疗质量。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: This study revealed patterns in osteoporosis patients' treatment preferences, which cannot be related to socio-demographic or clinical characteristics, implicating unknown underlying reasons. Therefore, to improve quality of care and treatment, patients should have an active role in treatment choice, irrespective of their characteristics. INTRODUCTION: Patient centeredness is important to improve the quality of care. Accounting for patient preferences is a key element of patient centeredness, and understanding preferences are important for successful and adherent treatment. This study was designed to identify different preferences profiles and to investigate how patient characteristics influence treatment preferences of patients for anti-osteoporosis drugs. METHODS: Data from a discrete choice experiment among 188 osteoporotic patients were used. The hypothetical treatment options were characterized by three attributes: treatment efficacy, side effects, and mode/frequency of administration. A mixed logit model was used to measure heterogeneity across the sample. Subgroup analyses were conducted to identify potential effect of patient characteristics. Latent class modeling (LCM) was applied. Associations between patients' characteristics and the identified latent classes were explored with chi-square. RESULTS: All treatment options were important for patients' decision regarding osteoporotic treatment. Significant heterogeneity was observed for most attributes. Subgroup analyses revealed that patients with a previous fracture valued efficacy most, and patients with a fear of needles or aged > 65 years preferred oral tablets. Elderly patients disliked intravenous medication. Three latent classes were identified, in which 6-month subcutaneous injection was preferred in two classes (86%), while oral tablets were preferred in the third class (14%). No statistically significant associations between the profiles regarding socio-demographic or clinical characteristics could be found. CONCLUSIONS: This study revealed patterns in patients' preferences for osteoporosis treatment, which cannot be related to specific socio-demographic or clinical characteristics. Therefore, patients should be involved in clinical decision-making to reveal their preferences.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Cornelissen D, Boonen A, Bours S, et al. Understanding patients' preferences for osteoporosis treatment: the impact of patients' characteristics on subgroups and latent classes. Osteoporos Int. 2019. PMID: 31606825. doi:10.1007/s00198-019-05154-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。